UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

BCL9 Promotes Tumor Progression by Conferring Enhanced Proliferative, Metastatic, and Angiogenic Properties to Cancer Cells

Cancer research (Chicago, Ill.), 2009-10, Vol.69 (19), p.7577-7586

2009

Volltextzugriff (PDF)

Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer

Cancer research (Chicago, Ill.), 1995-12, Vol.55 (23), p.5548-5550

1995

Volltextzugriff (PDF)

Mutational inactivation of transforming growth factor β receptor type II in microsatellite stable colon cancers

Cancer research (Chicago, Ill.), 1999-01, Vol.59 (2), p.320-324

1999

Volltextzugriff (PDF)

Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival

Oncotarget, 2015-10, Vol.6 (31), p.30500-30515

2015

Volltextzugriff (PDF)

A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability

Cancer research (Chicago, Ill.), 1995-12, Vol.55 (23), p.5545-5547

1995

Volltextzugriff (PDF)

Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor‐beta signaling in mouse intestinal neoplasms

International journal of cancer, 2017-02, Vol.140 (4), p.853-863

2017

Volltextzugriff (PDF)

Increased nm23-H1 and nm23-H2 Messenger RNA Expression and Absence of Mutations in Colon Carcinomas of Low and High Metastatic Potential

JNCI : Journal of the National Cancer Institute, 1993-01, Vol.85 (2), p.147-152

1993

Volltextzugriff (PDF)

Detection in Fecal DNA of Colon Cancer–Specific Methylation of the Nonexpressed Vimentin Gene

JNCI : Journal of the National Cancer Institute, 2005-08, Vol.97 (15), p.1124-1132

2005

Volltextzugriff (PDF)

Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor β resistant cells

Genes chromosomes & cancer, 2008-02, Vol.47 (2), p.95-106

2008

Volltextzugriff (PDF)

SLC5A8, a Sodium Transporter, Is a Tumor Suppressor Gene Silenced by Methylation in Human Colon Aberrant Crypt Foci and Cancers

Proceedings of the National Academy of Sciences - PNAS, 2003-07, Vol.100 (14), p.8412-8417

2003

Volltextzugriff (PDF)

HLTF Gene Silencing in Human Colon Cancer

Proceedings of the National Academy of Sciences - PNAS, 2002-04, Vol.99 (7), p.4562-4567

2002

Volltextzugriff (PDF)

Detection of TGF-beta type II receptor hot-spot mutations: the BAT-RII assay

Methods in molecular biology (Clifton, N.J.), 2000, Vol.142, p.133

2000

Volltextzugriff (PDF)

Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability

Science (American Association for the Advancement of Science), 1995-06, Vol.268 (5215), p.1336-1338

1995

Volltextzugriff (PDF)

Mutation of the type II transforming growth factor-β receptor is coincident with the transformation of human colon adenomas to malignant carcinomas

Cancer research (Chicago, Ill.), 1998-07, Vol.58 (14), p.3101-3104

1998

Volltextzugriff (PDF)

Nm23—Into the Basement (Membrane)

JNCI : Journal of the National Cancer Institute, 1994-12, Vol.86 (24), p.1815-1817

1994

Volltextzugriff (PDF)

Mutation detection in the TGF-beta receptors and smad genes: RT-PCR and sequencing

Methods in molecular biology (Clifton, N.J.), 2000, Vol.142, p.139

2000

Volltextzugriff (PDF)

Mutant K-ras oncogenes in colon cancers Do not predict Patient's chemotherapy response or survival

Clinical cancer research, 1995-04, Vol.1 (4), p.441-445

1995

Volltextzugriff (PDF)

What's new with RII?

Gastroenterology (New York, N.Y. 1943), 1997, Vol.112 (1), p.297-302

1997

Volltextzugriff (PDF)

Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells (∗)

The Journal of biological chemistry, 1995-09, Vol.270 (37), p.22044-22049

1995

Volltextzugriff (PDF)

Chromosomal autonomy of hMLH1 methylation in colon cancer

Oncogene, 2002-02, Vol.21 (9), p.1443-1449

2002

Volltextzugriff (PDF)

Chromosomal autonomy of hMLH1 methylation in colon cancer

Oncogene, 2002-02, Vol.21 (9), p.1443-1449

2002

Volltextzugriff (PDF)

A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene

The Journal of clinical investigation, 1994-03, Vol.93 (3), p.1005-1013

1994

Volltextzugriff (PDF)

Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential

JNCI : Journal of the National Cancer Institute, 1992-01, Vol.85 (2), p.147-152

1992

Volltextzugriff (PDF)

A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 suppressor gene

The Journal of clinical investigation, 1994, Vol.93 (3), p.1005-1013

1994

Volltextzugriff (PDF)

A transforming growth β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability

Cancer research (Chicago, Ill.), 1995, Vol.55 (23), p.5545-5547

1995

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

BCL9 Promotes Tumor Progression by Conferring Enhanced Proliferative, Metastatic, and Angiogenic Properties to Cancer Cells

Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer

Mutational inactivation of transforming growth factor β receptor type II in microsatellite stable colon cancers

Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival

A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability

Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor‐beta signaling in mouse intestinal neoplasms

Increased nm23-H1 and nm23-H2 Messenger RNA Expression and Absence of Mutations in Colon Carcinomas of Low and High Metastatic Potential

Detection in Fecal DNA of Colon Cancer–Specific Methylation of the Nonexpressed Vimentin Gene

Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor β resistant cells

SLC5A8, a Sodium Transporter, Is a Tumor Suppressor Gene Silenced by Methylation in Human Colon Aberrant Crypt Foci and Cancers

HLTF Gene Silencing in Human Colon Cancer

Detection of TGF-beta type II receptor hot-spot mutations: the BAT-RII assay

Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability

Mutation of the type II transforming growth factor-β receptor is coincident with the transformation of human colon adenomas to malignant carcinomas

Nm23—Into the Basement (Membrane)

Mutation detection in the TGF-beta receptors and smad genes: RT-PCR and sequencing

Mutant K-ras oncogenes in colon cancers Do not predict Patient's chemotherapy response or survival

What's new with RII?

Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells (∗)

Chromosomal autonomy of hMLH1 methylation in colon cancer

Chromosomal autonomy of hMLH1 methylation in colon cancer

A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene

Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential

A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 suppressor gene

A transforming growth β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability

Suchergebnisse filtern